1. Home
  2. INFU vs CDLX Comparison

INFU vs CDLX Comparison

Compare INFU & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InfuSystems Holdings Inc.

INFU

InfuSystems Holdings Inc.

N/A

Current Price

$9.42

Market Cap

182.4M

Sector

Health Care

ML Signal

N/A

Logo Cardlytics Inc.

CDLX

Cardlytics Inc.

N/A

Current Price

$0.68

Market Cap

69.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
INFU
CDLX
Founded
2005
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
182.4M
69.7M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
INFU
CDLX
Price
$9.42
$0.68
Analyst Decision
Strong Buy
Hold
Analyst Count
2
3
Target Price
$15.00
$2.25
AVG Volume (30 Days)
117.6K
687.5K
Earning Date
06-02-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
181.82
50.13
EPS
0.31
N/A
Revenue
$143,436,000.00
$233,273,000.00
Revenue This Year
$2.89
N/A
Revenue Next Year
$7.66
$46.84
P/E Ratio
$31.00
N/A
Revenue Growth
6.36
N/A
52 Week Low
$4.61
$0.67
52 Week High
$11.04
$3.28

Technical Indicators

Market Signals
Indicator
INFU
CDLX
Relative Strength Index (RSI) 58.49 30.12
Support Level $8.57 N/A
Resistance Level $9.80 $1.04
Average True Range (ATR) 0.53 0.07
MACD 0.10 -0.01
Stochastic Oscillator 80.15 3.99

Price Performance

Historical Comparison
INFU
CDLX

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

About CDLX Cardlytics Inc.

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Share on Social Networks: